肝细胞癌伴门静脉癌栓的介入综合治疗

伴门静脉癌栓(PVTT)的肝细胞癌(HCC)常见于进展期肝癌,PVTT可引起肿瘤播散、肝功能衰竭和门静脉高压,从而导致顽固性腹水、静脉曲张破裂和肝性脑病,严重影响肝癌患者预后。根据巴塞罗那临床肝癌分期(BCLC),伴PVTT的进展期HCC,索拉非尼被推荐为一线治疗方案,但由于其疗效有限且价格昂贵限制了它在国内的应用。而介入治疗以其微创、可重复性等优点在临床得到广泛应用,并取得一定的疗效。目前主要应用的介入治疗方法包括:经肝动脉灌注化疗术(HAIC)、经肝动脉化疗栓塞术(TACE)、TACE联合索拉非尼、TACE联合消融术、TACE联合适形放疗、TACE联合门静脉支架、门静脉粒子条置放术、经颈静...

Full description

Saved in:
Bibliographic Details
Published in临床肝胆病杂志 Vol. 31; no. 6; pp. 863 - 869
Main Author 朱晓黎
Format Journal Article
LanguageChinese
Published 苏州大学附属第一医院介入科,江苏苏州,215006 2015
Subjects
Online AccessGet full text
ISSN1001-5256
DOI10.3969/j.issn.1001-5256.2015.06.010

Cover

Abstract 伴门静脉癌栓(PVTT)的肝细胞癌(HCC)常见于进展期肝癌,PVTT可引起肿瘤播散、肝功能衰竭和门静脉高压,从而导致顽固性腹水、静脉曲张破裂和肝性脑病,严重影响肝癌患者预后。根据巴塞罗那临床肝癌分期(BCLC),伴PVTT的进展期HCC,索拉非尼被推荐为一线治疗方案,但由于其疗效有限且价格昂贵限制了它在国内的应用。而介入治疗以其微创、可重复性等优点在临床得到广泛应用,并取得一定的疗效。目前主要应用的介入治疗方法包括:经肝动脉灌注化疗术(HAIC)、经肝动脉化疗栓塞术(TACE)、TACE联合索拉非尼、TACE联合消融术、TACE联合适形放疗、TACE联合门静脉支架、门静脉粒子条置放术、经颈静脉肝内门体分流术(TIPS)等。最后指出多种方法综合治疗有望取得较好疗效。
AbstractList 伴门静脉癌栓(PVTT)的肝细胞癌(HCC)常见于进展期肝癌,PVTT可引起肿瘤播散、肝功能衰竭和门静脉高压,从而导致顽固性腹水、静脉曲张破裂和肝性脑病,严重影响肝癌患者预后。根据巴塞罗那临床肝癌分期(BCLC),伴PVTT的进展期HCC,索拉非尼被推荐为一线治疗方案,但由于其疗效有限且价格昂贵限制了它在国内的应用。而介入治疗以其微创、可重复性等优点在临床得到广泛应用,并取得一定的疗效。目前主要应用的介入治疗方法包括:经肝动脉灌注化疗术(HAIC)、经肝动脉化疗栓塞术(TACE)、TACE联合索拉非尼、TACE联合消融术、TACE联合适形放疗、TACE联合门静脉支架、门静脉粒子条置放术、经颈静脉肝内门体分流术(TIPS)等。最后指出多种方法综合治疗有望取得较好疗效。
R735.7; 伴门静脉癌栓(PVTT)的肝细胞癌(HCC)常见于进展期肝癌,PVTT可引起肿瘤播散、肝功能衰竭和门静脉高压,从而导致顽固性腹水、静脉曲张破裂和肝性脑病,严重影响肝癌患者预后.根据巴塞罗那临床肝癌分期(BCLC),伴PVTT的进展期HCC,索拉非尼被推荐为一线治疗方案,但由于其疗效有限且价格昂贵限制了它在国内的应用.而介入治疗以其微创、可重复性等优点在临床得到广泛应用,并取得一定的疗效.目前主要应用的介入治疗方法包括:经肝动脉灌注化疗术(HAIC)、经肝动脉化疗栓塞术(TACE)、TACE联合索拉非尼、TACE联合消融术、TACE联合适形放疗、TACE联合门静脉支架、门静脉粒子条置放术、经颈静脉肝内门体分流术(TIPS)等.最后指出多种方法综合治疗有望取得较好疗效.
Author 朱晓黎
AuthorAffiliation 苏州大学附属第一医院介入科,江苏苏州215006
AuthorAffiliation_xml – name: 苏州大学附属第一医院介入科,江苏苏州,215006
Author_FL ZHU Xiaoli
Author_FL_xml – sequence: 1
  fullname: ZHU Xiaoli
Author_xml – sequence: 1
  fullname: 朱晓黎
BookMark eNo9j09Lw0AUxPdQwVr7JcSDl8T3drMvzVGK_6DgpfeSbJKaUjfaIGKPWkXRgyBYKlS8CJ7FW_px2ib9FkYqnoYZfswwa6ykYx0wtolgCoec7Y4ZJYk2EQANySWZHFCaQCYglFj5P19l1SSJPJAoyLEklZnIr8ZZeptfv2Wjx-nkezH8XIxH-eC-sPP35-x1ME0fZjcfWTqZPd3Nv9LsZbjOVkK3mwTVP62w5t5us35gNI72D-s7DUMRgEFIyufCcyRXgS-5y4kHHKSwArumamjxkKNn--jxkOxAFJ7QtS2SSjkhB1FhW8vaC1eHrm63OvF5TxeDra5q-16__3sSqLhYoBtLVB3Hun0WFfBpLzpxe5ctImkRIljiB9ZlZ0Q
ClassificationCodes R735.7
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W91
~WA
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.3969/j.issn.1001-5256.2015.06.010
DatabaseName 维普期刊资源整合服务平台
中文科技期刊数据库-CALIS站点
维普中文期刊数据库
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Comprehensive interventional treatment of hepatocellular carcinoma with portal vein tumor thrombosis
DocumentTitle_FL Comprehensive interventional treatment of hepatocellular carcinoma with portal vein tumor thrombosis
EndPage 869
ExternalDocumentID lcgdbzz201506010
665461104
GroupedDBID -05
2B.
2C~
2RA
5XA
5XF
92F
92I
92L
ABDBF
ACGFS
ALMA_UNASSIGNED_HOLDINGS
CCEZO
CIEJG
CQIGP
CW9
EAD
EAP
EOJEC
ESX
GROUPED_DOAJ
IPNFZ
OBODZ
OK1
RIG
RNS
TCJ
TGQ
U1G
U5O
W91
~WA
4A8
93N
ABJNI
ACUHS
PSX
ID FETCH-LOGICAL-c600-616cd23b952ced52a262e20534e78c8142f21b7d1b2f67e342f61a7465cc9f203
ISSN 1001-5256
IngestDate Thu May 29 03:59:49 EDT 2025
Wed Feb 14 10:30:10 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords 综合疗法
combined modality therapy
portal vein tumor thrombosis
carcinoma,hepatocellular
门静脉癌栓
癌,肝细胞
Language Chinese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c600-616cd23b952ced52a262e20534e78c8142f21b7d1b2f67e342f61a7465cc9f203
Notes Portal vein tumor thrombosis( PVTT) often occurs in advanced hepatocellular carcinoma( HCC) patients. PVTT may cause tumor dissemination,liver failure,and portal hypertension,thus leading to intractable ascites,variceal rupture,and hepatic encephalopathy,which will result in a poor prognosis. According to the Barcelona Clinic Liver Cancer Staging System,sorafenib is recommended as the first- line treatment for advanced HCC with PVTT,but its application in China has been limited due to its mild efficacy and high price.Nowadays,interventional treatment is widely used in the treatment of advanced HCC with PVTT due to the advantages of minimal invasiveness and repeatability and shows good efficacy. At present,the main methods of interventional treatment include hepatic arterial infusion chemotherapy,transcatheter arterial chemoembolization( TACE),TACE combined with sorafenib,TACE combined with ablation,TACE combined with three- dimensional conformal radiotherapy,TACE combined with portal vein stent placement,endo
PageCount 7
ParticipantIDs wanfang_journals_lcgdbzz201506010
chongqing_primary_665461104
PublicationCentury 2000
PublicationDate 2015
PublicationDateYYYYMMDD 2015-01-01
PublicationDate_xml – year: 2015
  text: 2015
PublicationDecade 2010
PublicationTitle 临床肝胆病杂志
PublicationTitleAlternate Chinese Journal of Clinical Hepatology
PublicationTitle_FL Journal of Clinical Hepatology
PublicationYear 2015
Publisher 苏州大学附属第一医院介入科,江苏苏州,215006
Publisher_xml – name: 苏州大学附属第一医院介入科,江苏苏州,215006
SSID ssib051369456
ssj0041983
ssib001103858
ssib053243598
ssib002264326
ssib038074677
Score 2.0038993
Snippet 伴门静脉癌栓(PVTT)的肝细胞癌(HCC)常见于进展期肝癌,PVTT可引起肿瘤播散、肝功能衰竭和门静脉高压,从而导致顽固性腹水、静脉曲张破裂和肝性脑病,严重影响肝癌患者预后。...
R735.7; 伴门静脉癌栓(PVTT)的肝细胞癌(HCC)常见于进展期肝癌,PVTT可引起肿瘤播散、肝功能衰竭和门静脉高压,从而导致顽固性腹水、静脉曲张破裂和肝性脑病,严重影响肝癌患者...
SourceID wanfang
chongqing
SourceType Aggregation Database
Publisher
StartPage 863
SubjectTerms 癌,肝细胞
综合疗法
门静脉癌栓
Title 肝细胞癌伴门静脉癌栓的介入综合治疗
URI http://lib.cqvip.com/qk/90100X/201506/665461104.html
https://d.wanfangdata.com.cn/periodical/lcgdbzz201506010
Volume 31
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVEBS
  databaseName: Academic Search Ultimate
  issn: 1001-5256
  databaseCode: ABDBF
  dateStart: 20130401
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  isFulltext: true
  dateEnd: 99991231
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  omitProxy: true
  ssIdentifier: ssj0041983
  providerName: EBSCOhost
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  issn: 1001-5256
  databaseCode: M~E
  dateStart: 19850101
  customDbUrl:
  isFulltext: true
  dateEnd: 99991231
  titleUrlDefault: https://road.issn.org
  omitProxy: true
  ssIdentifier: ssib053243598
  providerName: ISSN International Centre
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NaxNBFB9iCsWL-Im1KhWcY-rufO3McTfZUIR6itBb2N1sUkFSP9JLTqJVFD0IgqVCxYvgWbylf07bpP-F781O0q1KUS_L7JvZN2_2zbz5zTDvDSG3_dTkUnFYqeYyqIkkZTXAyRxWKZ6X6ZxLEaC_8-o9tXJf3F2Ta5XKs9Kppc1BupwN_-hX8j9aBRroFb1k_0GzM6ZAgDToF56gYXj-lY5prKlm1DRoHNAoolpZCqcmRooxVNdpLGhUp5GgsaEmoKG2iQbmYmHAkqZUWNHQo4ZbSoi5-DlwjmgsqZY0lK4u4AkU41Gt8auIIRG_UrQ4CjuFvJaDtgJIGgHPsCS2lRbFDlA24A-sgA65WLg5ZQU9wuZAO3ybMFZGY0WLyzsXhdemM7N4kEuyIqT41A672eDBb0ZVOxPo5ufiapdfTT83yljTjxUszyrAw3vSRmh1p2dPBtfGu5cVICBxhswx3NGpkrkwakTNY0jpeyfi_aDjcQnyYrx-UQoJKH2ujDiOTyQBsGKQxCk6EL7RhdOHE3Aexksh_Z3TZMfQH-sb_d5jADTWv6zfTfq9EhRqnSfn3BpmKSw65AVSGa5fJPOr7pTGJcInz3fHo1eTF5_HO-_2934cbX872t2ZbL2B18MvH8aftvZHbw9efh2P9g7evz78Php_3L5MWs24VV-pucs5ahlgZBjLKuswnhrJsrwjWcIUyxk0V-SBzrQvWJf5adDxU9ZVQc7hXfkJ_CqZZabLPH6FVPsb_fwqWTJppjt5qj3RzQXvGphRMiNEEiQ8UdpLFsjirOntR0UMlvZMcQvklvsZbTcyn7YfZr1OOhyyInym7107lcMiOYsli32166Q6eLKZ3wCkOUhvus7wE52uXx8
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E8%82%9D%E7%BB%86%E8%83%9E%E7%99%8C%E4%BC%B4%E9%97%A8%E9%9D%99%E8%84%89%E7%99%8C%E6%A0%93%E7%9A%84%E4%BB%8B%E5%85%A5%E7%BB%BC%E5%90%88%E6%B2%BB%E7%96%97&rft.jtitle=%E4%B8%B4%E5%BA%8A%E8%82%9D%E8%83%86%E7%97%85%E6%9D%82%E5%BF%97&rft.au=%E6%9C%B1%E6%99%93%E9%BB%8E&rft.date=2015&rft.issn=1001-5256&rft.volume=31&rft.issue=6&rft.spage=863&rft.epage=869&rft_id=info:doi/10.3969%2Fj.issn.1001-5256.2015.06.010&rft.externalDocID=665461104
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F90100X%2F90100X.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Flcgdbzz%2Flcgdbzz.jpg